Roche Holding AG (OTCMKTS:RHHBY) Receives $40.00 Consensus Price Target from Analysts

Roche Holding AG (OTCMKTS:RHHBY) has been given an average rating of “Hold” by the seven research firms that are covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and one has given a buy rating to the company. The average 12-month price target among analysts that have covered the stock in the last year is $40.00.

RHHBY has been the subject of a number of recent analyst reports. Argus restated a “hold” rating on shares of Roche in a research note on Monday, March 4th. Deutsche Bank Aktiengesellschaft raised Roche from a “sell” rating to a “hold” rating in a report on Friday, May 17th.

Roche Stock Performance

Shares of OTCMKTS RHHBY opened at $31.60 on Monday. Roche has a fifty-two week low of $29.20 and a fifty-two week high of $40.48. The business has a 50 day moving average price of $31.02 and a two-hundred day moving average price of $33.26. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.04 and a current ratio of 1.35.

Institutional Trading of Roche

Several hedge funds have recently made changes to their positions in the stock. First Horizon Advisors Inc. lifted its holdings in shares of Roche by 19.8% in the 4th quarter. First Horizon Advisors Inc. now owns 2,066 shares of the company’s stock worth $75,000 after purchasing an additional 342 shares during the last quarter. Bard Financial Services Inc. lifted its holdings in shares of Roche by 2.0% in the 1st quarter. Bard Financial Services Inc. now owns 20,200 shares of the company’s stock worth $645,000 after purchasing an additional 400 shares during the last quarter. SVB Wealth LLC lifted its holdings in shares of Roche by 2.6% in the 1st quarter. SVB Wealth LLC now owns 16,646 shares of the company’s stock worth $531,000 after purchasing an additional 426 shares during the last quarter. Hancock Whitney Corp lifted its holdings in shares of Roche by 2.4% in the 1st quarter. Hancock Whitney Corp now owns 28,995 shares of the company’s stock worth $926,000 after purchasing an additional 678 shares during the last quarter. Finally, AlphaMark Advisors LLC bought a new stake in shares of Roche in the 1st quarter worth approximately $34,000.

About Roche

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.